Citi raised the firm’s price target on Clorox to $160 from $150 and keeps a Buy rating on the shares after meeting with management. The analyst came away from the meeting with increased conviction that Clorox should continue to recover shelf-space and market share as the cyberattack impacts are behind it, as evidenced by the sequential improvement in scanner data trends. The firm continue to think the company’s fiscal 2024 guidance “reflects a healthy dose of conservatism.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CLX:
- Baidu upgraded, Foot Locker downgraded: Wall Street’s top analyst calls
- Clorox upgraded to Neutral from Underweight at JPMorgan
- Clorox price target raised to $162 from $152 at DA Davidson
- Clorox board elects CEO Linda Rendle to the role of chair
- Clorox participates in a conference call with DA Davidson
